Russell Investments Group
KERX

Russell Investments Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Russell Investments Group’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-49,026
Closed -$184K – 3063
2018
Q2 		$184K Hold
49,026
– – ﹤0.01% 2648
2018
Q1 		$201K Buy
+49,026
New +$228K ﹤0.01% 2659
2017
Q4 		– Sell
-754,631
Closed -$5.36M – 3056
2017
Q3 		$5.36M Buy
754,631
+665,069
+743% +$4.78M 0.01% 1234
2017
Q2 		$648K Buy
+89,562
New +$560K ﹤0.01% 2320

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group's KERX Position: Q3 2018 in Review

Russell Investments Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 49,026 shares — an estimated $184K sold.

Russell Investments Group first reported a position in KERX in Q2 2017 and held it in 4 quarters. The position peaked at $5.36M in Q3 2017. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.

  • Russell Investments Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Russell Investments Group sold 49,026 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $184K.
  • Russell Investments Group first reported a position in Keryx Biopharmaceuticals Inc in Q2 2017 and held it in 4 quarters.
  • Russell Investments Group's Keryx Biopharmaceuticals Inc position peaked at $5.36M in Q3 2017.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.

Based on Russell Investments Group's 13F filing for Q3 2018, filed 26 Oct 2018.